Royal Bank of Scotland has launched an Intellectual Property lending product that allows businesses to borrow between £250,000 and £10 million secured against the value of their IP portfolio rather than physical assets. Holmes Mackillop Solicitors, one of Scotland's established commercial law firms, has publicly welcomed the move as a material new route to early-stage and growth finance for Scottish businesses that have historically struggled to access traditional secured lending.

The structural problem this solves is real and long-standing. A manufacturing firm with a factory and fleet can walk into almost any bank and raise debt against those assets. A software company, a biotech spinout, a creative agency, or a brand-led consumer business has always faced a different conversation: the bank looks for collateral, finds intangibles, and the deal often stalls. According to the British Business Bank's 2023 Small Business Finance Markets report, access to finance remains one of the top three barriers for high-growth UK SMEs, with asset-light firms consistently underserved by mainstream lending products.

Scotland is disproportionately well-placed to benefit from this shift. The country's university commercialisation pipeline, particularly from Edinburgh, Glasgow, St Andrews, and Strathclyde, produces a steady stream of IP-heavy spinouts in life sciences, clean energy, and deep tech. Scottish Enterprise has long identified these sectors as central to Scotland's economic growth strategy, and funding gaps at the early commercial stage have been a persistent friction point that grants and equity alone haven't fully resolved.

Holmes Mackillop's endorsement matters here beyond the PR value. Commercial solicitors who work daily with founders on IP registration, licensing, and protection are well placed to judge whether a lending product is structured in a way that actually fits how IP works legally. Their welcome suggests the RBS product has been designed with genuine commercial input rather than bolted onto an existing framework as an afterthought. The Intellectual Property Office has been pushing for greater IP-backed finance across the UK since its 2021 report identified an estimated £4.4 trillion in unmonetised intangible assets sitting across British businesses.

For Scottish SMEs specifically, the timing aligns with a broadening of funding options that includes the Scottish National Investment Bank's patient capital mandate, Scottish EDGE grant competitions, and Innovate UK's continued commitment to R&D-intensive businesses north of the border. IP lending doesn't replace equity or grant funding; it sits alongside them, giving founders a non-dilutive route to capital at a moment when many are reluctant to give away more of the company to raise the working capital they need to scale.